期刊文献+

PML-RARα对环腺苷酸诱导急性髓系白血病细胞分化的影响 被引量:1

Effects of PML-RARα on cAMP-induced AML Cell Differentiation
下载PDF
导出
摘要 为了进一步探讨环腺苷酸cAMP协同低剂量氧化砷诱导急性早幼粒白血病细胞分化的分子机制,以稳定转染了PML-RARα融合基因的PR9细胞为实验对象,通过观察细胞的生长,并利用形态学实验、流式细胞技术和荧光素酶报告基因转染实验等检测cAMP和/或氧化砷处理前后细胞相关指标的变化,研究PML-RARα在cAMP诱导AML细胞分化过程中的作用。结果显示,虽然cAMP单独能使表达PML-RARα的PR9细胞表面分化抗原CD11b的阳性率有所升高;但细胞形态学分析表明,cAMP单用无法诱导表达PML-RARα融合蛋白的PR9细胞分化,只有联合氧化砷才能使细胞表现出完全分化的特征,并伴有CD11b表达的显著升高。此外,PML-RARα还可以明显抑制含有cAMP反应元件的报告基因的转录。结论:PML-RARα融合蛋白对cAMP诱导AML细胞分化的信号转导途径具有显著的抑制作用。 To explore the molecular mechanisms of acute promyelocytic leukemia cell differentiation induced by cAMP combined with low-dose As2O3 , the PR9 cell line, which was stably transfected by PML-RARα fusion gene, was used as in vitro model. The effects of PML-RARα on cAMP-induced AML cell differentiation were evaluated according to cell growth, cell morphology, cell surface antigen as well as luciferase reporter gene assay, in the cells before and after the treatment with cAMP and/or AS2O3. The results showed that cAMP alone could slightly increase the expression of CDllb in the PR9 cells expressing the PML-RARα fusion protein, but could not induce these cells to differentiate. The cells presented the terminal differentiation morphology and significantly increased CD11b expression only under the treatment of cAMP combined with As2O3. In addition, PML-RARα had strong inhibitory activity on the transcription of the reporter gene containing cAMP response elements. In conclusions, the PML-RARα fusion protein could dramatically block the signaling pathway of cAMP during the AML cell differentiation.
出处 《中国实验血液学杂志》 CAS CSCD 2008年第6期1275-1278,共4页 Journal of Experimental Hematology
基金 国家自然科学基金(编号30570778,30670882) 863计划(编号2006AA02Z19A) 上海市教委曙光计划(2003年度) 上海市人才发展基金(童建华)
关键词 环腺苷酸 PML—RARα融合蛋白 急性髓系白血病 细胞分化 cyclic adenosine monophosphate PML-RARα fusion protein acute myeloid leukemia cell differentiation
  • 相关文献

参考文献11

  • 1窦爱霞,童建华.cAMP信号途径和基因表达调控[J].上海第二医科大学学报,2004,24(12):1070-1073. 被引量:6
  • 2Zhu Q, Zhang JW, Zhu HQ, et al. Synergic effects of arsenic trioxide and cAMP during acute promyelocytic leukemia cell maturation subtends a novel signaling cross-talk. Blood, 2002; 99:1014 - 1022
  • 3Grignani F, Testa U, Rogaia D, et al. Effects on differentiation by the promyelocytic leukemia PMIZRARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains. EMBO J, 1996; 15:4949-4958
  • 4Tong JH, Chen S J, Chen Z. Retinoic acid and arsenic trioxide treatment in acute promyelocytic leukemia: a model of oncoprotein targeted therapy (Chapter 15 ). In: huang zw. drug discovery research-New Frontiers in the Post-Genomic Era. Wiley-Interscience, A John Wiley & Sons, Inc., 2007:373-392
  • 5Fang J, Chen SJ, Tong JH, et al. Treatment of acute promyelocytic leukemia with ATRA and As2 03 : a model of molecular target-based cancer therapy. Cancer Biol Ther, 2002 ; 1 : 614 - 620
  • 6Benoit G, Roussel M, Pendino F, et al. Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t (15;17) preleukemic blast and APL-cell maturation. Oncogene, 2001; 20:7161 -7177
  • 7Zhao Q, Tao J, Zhu Q, et al. Rapid induction of cAMP/PKA pathway during retinoic acid-induced acute promyalocytic leukemia cell differentiation. Leukemia, 2004; 18: 285- 292
  • 8Guillemin MC, Raffoux E, Vitoux D, et al. In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia. J Exp Med, 2002 ; 196 : 1373 - 1380
  • 9Honma Y, Kasukabe T, Hozumi M. Induction of lysozyme activity by adenosine 3 : 5 cyclic monophosphate in cultured mouse myeloid leukemic ceils. Biochem Biophys Res Commun, 1978; 82:1246 - 1250
  • 10Tortora G, Tagliaferri P, Clair T, et al. Site-selective cAMP analogs at micromolar concentrations induce growth arrest and differentiation of acute promyelocytic, chronic myelocytic, and acute lymphocytic human leukemia cell lines. Blood, 1988 ; 71:230 - 233

二级参考文献16

  • 1Houslay MD, Milligan G. Tailoring cAMP-signalling responses through isoform multiplicity [ J]. Trends Biochem Sci, 1997, 22(6): 217 -224.
  • 2Rich TC, Karpen JW. Cyclic AMP sensors in living cells: what signals can they actually measure [ J ] ? Ann Biomed Eng, 2002, 30(8): 1 088 -1 099.
  • 3Qi M, Zhuo M, Skalhegg BS, et al. Impaired hippocampal plasticity in mice lacking the Cbetal catalytic subunit of cAMP-dependent protein kinase [J]. Proc Natl Acad Sci USA,1996,93(4): 1 571 -1576.
  • 4Dell'Acqua ML, Dodge KL, Tavalin SJ, et al. Mapping the protein phosphatase-2B anchoring site on AKAP79. Binding and inhibition of phosphatase activity are mediated by residues 315 ~ 360 [ J ]. J Biol Chem, 2002, 277 (50): 48 796-48 802.
  • 5Saeki K, Yuo A. Distinct involvement of cAMP-response elementdependent transcriptions in functional and morphological maturation during retinoid-mediated human myeloid differentiation [ J ]. Journal of Leukocyte Biology, 2003, 73 (5): 673 - 681.
  • 6Studzinski GP, Harrison LE. Differentiation-related changes in the cell cycle traverse[ J]. Int Rev Cytol, 1999, 189:1 -58.
  • 7Jaramillo M, Olivier M. Hydrogen peroxide induces murine macrophage chemokine gene transcription via extracellular signal-regulated kinase- and cyclic adenosine 5'-monophosphate (cAMP) -dependent pathways: involvement of NF-kappa B, activator protein 1, and cAMP response element binding protein[ J]. J Immunol, 2002, 169(12): 7 026 -7 038.
  • 8Garg A,Aggarwal BB. Nuclear transcription factor-kappaB as a target for cancer drug development [ J ]. Leukemia, 2002, 16 (6):1 053 -1 068.
  • 9Zhong H, SuYang H, Erdjument-Bromage H, et al. The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism [J].Cell, 1997, 89 (3): 413 -424.
  • 10Michael D, Vigne JL, Minchenko A, et al. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta [ J]. Proc Natl Acad Sci USA, 2000, 97(20): 10 972 -10 977.

共引文献8

同被引文献19

  • 1Caers J, Vande-broek I, De-Raeve H, et al. Multiple myeloma--an update on diagnosis and treatment. Eur J Haematol, 2008 ; 81 ( 5 ) : 329 - 343.
  • 2Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin, 2009 ;59(4) :225 -349.
  • 3Ludwig H. Advances in biology and treatment of multiple myeloma. Ann Oncol, 2005 ; 16 ( Suppl ; 2 ) : ii106 - 112.
  • 4Hideshima T, Mitsiades C, Tonon G, et al. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer, 2007 ;7(8) :585 -598.
  • 5Goasguen JE, Zandecki M, Mathiot C ,et al. Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphology. Leuk Res, 1999 ;23 (12) :1133 -1140.
  • 6Bataille R, Jego G, Robillard N, et al. The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy. Haematologica, 2006 ;91 ( 9 ) : 1234 - 1240.
  • 7Greipp PR, Raymond NM, Kyle RA, et al. Multiple myeloma: significance of plasmablastic subtype in morphological classification. Blood, 1985 ;65(2) :305 -310.
  • 8Amadori S, Fenaux P, Ludwig H, et al. Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent. Curr Med Res Opin, 2005 ;21 (3) :403 - 411.
  • 9Chen-Kiang S. Biology of plasma cells. Best Pract Res Clin Haematol, 2005 ; 18 (4) :493 - 507.
  • 10Hou J, Xiong H, Gao W, et al. 2-Methoxyestradiol at low dose induces differentiation of myeloma cells. Leuk Res, 2005 ; 29 ( 9 ) : 1059 - 1067.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部